Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: R35 GM131812
National Institutes of Health
Grant: 5T32GM008425-09
CLINICAL PHARMACOLOGY TRAINING GRANT
National Institutes of Health
Grant: 5R35GM131812-02
MIRA-Regulation of drug metabolizing enzymes
Vera Bradley Foundation for Breast Cancer
National Human Genome Research Institute
National Institute of General Medical Sciences
FWCI
1.21
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals